• Jennifer Whitty Jennifer Whitty
  • Caroline Tallis Caroline Tallis
  • Kim-Huong Nguyen Kim-Huong Nguyen
  • Paul Scuffham Paul Scuffham
  • Paul Crosland Paul Crosland
  • Kaye Hewson Kaye Hewson
  • Rehka Pai Mangalore Rehka Pai Mangalore
  • Marrianne Black Marrianne Black
  • Gerald Holtmann Gerald Holtmann

Background: Treatment uptake amongst patients with chronic Hepatitis C virus (HCV) in Australia is relatively low. New approaches to assessment have the potential to reduce public waiting lists, improve access to treatment, and to reduce healthcare costs. Aim: To describe the costs to the public hospital system and waiting time associated with a novel integrated rapid access to assessment and treatment (RAAT) model of care that utilizes Transient Elastography (TE) as a specialist outpatient-based approach for a streamlined assessment of patients with chronic HCV, compared to conventiol outpatient magement with liver biopsy (LB). Methods: Time from first medical review to treatment plan and costs associated with detection of fibrosis were recorded for patients receiving RAAT during a 3-month period, and for a similar historical cohort maged conventiolly with LB. Costs related to medical and multidiscipliry team reviews and the TE/LB test itself were included. Results: Patients receiving RAAT had lower costs (n?=?27, median AU$2716) and shorter time to treatment (median?=?194 days) than for conventiol magement (n?=?13, median $5005, 420 days; p?